Trial Profile
Subcutaneous administration of campath-1H [alemtuzumab], a single institution experience
Status:
Not stated
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 26 Feb 2007
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- 26 Feb 2007 New trial record.